Skip to content
healthcare.dev

NINLARO

NDC 63020-400, ixazomib, capsule, from Takeda Pharmaceuticals America, Inc..

Product NDC
63020-400
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208462
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63020-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IXAZOMIB CITRATE4 mg/1

Pharmacologic classes

Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]

Package NDCNDC-11Package
63020-400-01630200400011 CAPSULE in 1 BLISTER PACK (63020-400-01)
63020-400-02630200400021 BLISTER PACK in 1 CARTON (63020-400-02) / 3 CAPSULE in 1 BLISTER PACK (63020-400-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/038f2461-834b-4488-9ebd-863c83eef5a7

Use it

Look up 63020-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63020-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63020-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.